Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure

Europace

Volumn 10, Issue 4, 2008, Pages 496-501

  Lancellotti, Patrizio ^a   Cosyns, Bernard ^b   Piérard, Luc A ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b Centre Hospitalier interregional Edith Cavell   (Belgium)

Author keywords

B type natriuretic peptide; Exercise; Heart failure; LV dyssynchrony; Mitral regurgitation

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; EXERCISE; HEART HEMODYNAMICS; HEART LEFT VENTRICLE FAILURE; HUMAN; LEFT VENTRICULAR DYSSYNCHRONY; MAJOR CLINICAL STUDY; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; QUANTITATIVE ANALYSIS; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HEART FAILURE;

AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; ELECTROCARDIOGRAPHY; EXERCISE; EXERCISE TOLERANCE; HEART FAILURE, SYSTOLIC; HUMANS; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MULTIVARIATE ANALYSIS; NATRIURETIC PEPTIDE, BRAIN; PROGNOSIS; REGRESSION ANALYSIS; REST; SEVERITY OF ILLNESS INDEX; VENTRICULAR DYSFUNCTION, LEFT;

EID: 44449129414     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eun040     Document Type: Article

References (30)

1. de Groote P, Dagorn J, Soudan B, Lamblin N, McFadden E, Bauters C. B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure. J Am Coll Cardiol 2004;43:1584-9.
2. Detaint D, Messika-Zeioun D, Chen HH, Rossi A, Avierinos JF, Scott C et al. Association of B-type natriuretic peptide activation to left ventricular end-systolic remodeling in organic and functional mitral regurgitation. Am J Cardiol 2006;97:1029-34.
3. Sutton TM, Stewart RA, Gerber IL, West TM, Richards AM, Yandle TG et al. Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation. J Am Coll Cardiol 2003;18:2280-7.
4. Patrianakos AP, Parthenakis FI, Papadimitriou EA, Diakakis GF, Tzerakis PG, Nikitovic D et al. Restrictive filling pattern is associated with increased humoral activation and impaired exercise capacity in dilated cardiomyopathy. Eur J Heart Fail 2004;6:735-43.
5. O'Donoghue M, Chen A, Baggish AL, Anwaruddin S, Krauser DG, Tung R et al. The effects of ejection fraction on N-terminal ProBNP and BNP levels in patients with acute CHF: analysis from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study. J Card Fail 2005;11:S9- S14.
6. Heeschen C, Hamm CW, Mitrovic V, Lantelme NH, White HD; for the Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Investigators N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 2004;110:3206-12.
7. Binder L, Pieske B, Olschewski M, Geibel A, Klostermann B, Reiner C et al. N-terminal pro-brain natriuretic peptide or troponin testing followed by echocardiography for risk stratification of acute pulmonary embolism. Circulation 2005;112:1573-9.
8. Sabatine MS, Morrow DA, de Lemos JA, Sabatine MS, Murphy SA, Rifai N et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004 44:1988-95.
9. Lancellotti P, Stainier PY, Lebois F, Piérard L. Effect of dynamic left ventricular dyssynchrony on dynamic mitral regurgitation in patients with heart failure due to coronary artery disease. Am J Cardiol 2005;96:1304-7.
10. Bodarchar P, Lafitte S, Reuter S, Serri K, Garrigue S, Laborderie J et al. Echocardiographic assessment during exercise of heart failure patients with cardiac resynchronization therapy. Am J Cardiol 2006;97:622- 1625.
11. Madaric J, Vanderheyden M, Van Laethem C, Verhamme K, Feys A, Goethals M et al. Early and late effects of cardiac resynchronization therapy on exercise-induced mitral regurgitation: relationship with left ventricular dyssynchrony, remodelling and cardiopulmonary performance. Eur Heart J 2007;28:2134-41.
12. Lancellotti P, Benoit T, Rigo P, Piérard L. Dobutamine stress echocardiography versus quantitative technetium-99m Sestamibi SPECT for detecting residual stenosis and multivessel disease after myocardial infarction. Heart 2001;86:510-5.
13. Lebrun F, Lancellotti P, Piérard LA. Quantitation of functional mitral regurgitation during bicycle exercise in patients with heart failure. J Am Coll Cardiol 2001;38:1685-92.
14. Hall C. NT-proBNP: the mechanism behind the marker. J Card Fail 2005; 11:S81-S83.
15. Kawai K, Hata K, Tanaka K, Kubota Y, Inoue R, Masuda E et al. Attenuation of biologic compensatory action of cardiac natriuretic peptide system with aging. Am J Cardiol 2004;93:719-23.
16. Wang TJ, Larson MG, Levy D, Benjamin EJ, Leip EP, Wilson PW et al. Impact of obesity on plasma natriuretic peptide levels. Circulation 2004;109:594-600.
17. Tsutamoto T, Wada A, Sakai H, Ishikawa C, Tanaka T, Hayashi M et al. Relationship between renal function and plasma brain natriuretic peptide in patients with heart failure. J Am Coll Cardiol 2006;47:582-6.
18. Mak GS, DeMaria A, Clopton P, Maisel AS. Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. Am Heart J 2004;148:895-902.
19. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 2001;103:1759-64.
20. Wijbenga JA, Balk AH, Boomsma F, Man in 't Veld AJ, Hall C. Cardiac peptides differ in their response to exercise. Implications for patients with heart failure in clinical practice. Eur Heart J 1999;20:1424-8.
21. Bentzen H, Pedersen RS, Nyvad O, Pedersen EB. Effect of exercise on natriuretic peptides in plasma and urine in chronic heart failure. Int J Cardiol 2004;93:121-30.
22. de Groote P, Soudan B, Lamblin N, Rouaix-Emery N, Mc Fadden E, Meurice Tet al. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure? Am Heart J 2004;148:349-55.
23. Mottram PM, Haluska BA, Marwick TH. Response of B-type natriuretic peptide to exercise in hypertensive patients with suspected diastolic heart failure: correlation with cardiac function, hemodynamics, and workload. Am Heart J 2004;148:365-70.
24. Friedl W, Mair J, Thomas S, Puschendorf B. Relationship between natriuretic peptides and hemodynamics in patients with heart failure at rest and after ergometric exercise. Clin Chim Acta 1999;28:121-6.
25. Piérard LA, Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 2004;351:627-1634.
26. Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH et al. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation 1996;93:2059- 67.
27. Wang R, Li X, Jang W, Liu Z, Yang X, Xiao C et al. Blood B-type natriuretic peptide changes in different periods and different cardiac pacing modes. Int Heart J 2005;46:1015-22.
28. Kruger S, Graf J, Merx MW, Stickel T, Kunz D, Hanrath P et al. Brain natriuretic peptide kinetics during dynamic exercise in patients with chronic heart failure. Int J Cardiol 2004;95:49-54.
29. de Bold AJ, Bruneau BG, Kuroski de Bold ML. Mechanical and neuroendocrine regulation of the endocrine heart. Cardiovasc Res 1996;31:7-18.
30. Wang M, Yip G, Yu CM, Zhang Q, Zhang Y, Tse D et al. Independent and incremental prognostic value of early mitral annulus velocity in patients with impaired left ventricular systolic function. J Am Coll Cardiol 2005;45:272-7.